SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-064184
Filing Date
2020-12-17
Accepted
2020-12-17 18:08:22
Documents
1
Period of Report
2020-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3501
  Complete submission text file 0001209191-20-064184.txt   5222
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1020 KIFER ROAD SUNNYVALE CA 94086
Business Address 1020 KIFER ROAD SUNNYVALE CA 94086 408-523-7587
Myriam Curet (Reporting) CIK: 0001632901 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 201397327